XML 37 R36.htm IDEA: XBRL DOCUMENT v3.20.1
Note 15 - Share-based Compensation (Tables)
6 Months Ended
Mar. 31, 2020
Notes Tables  
Schedule of Share-based Payment Award, Stock Options, Valuation Assumptions [Table Text Block]
Volatility
   
44.5
%
Risk Free Interest Rate
   
1.40
%
Forfeiture rate
   
10.0
%
Dividend Yield
   
0.0
%
Expected life in years
   
5.35
 
Schedule of Nonvested Restricted Stock Units Activity [Table Text Block]
   
Number of
Shares
   
Weighted
Average Grant
Date Fair Value
 
Outstanding September 30, 2019
   
274,849
    $
2.59
 
Granted
   
231,270
    $
2.95
 
Released
   
(198,106
)   $
2.66
 
Forfeited/cancelled
   
(4,999
)   $
2.58
 
Outstanding March 31, 2020
   
303,014
    $
2.82
 
Share-based Payment Arrangement, Option, Activity [Table Text Block]
   
Number of
Shares
   
Weighted
Average
Exercise Price
 
Outstanding September 30, 2019
   
2,219,268
    $
1.94
 
Granted
   
1,133,727
    $
3.39
 
Forfeited/expired
   
(109,233
)   $
2.11
 
Exercised
   
(140,204
)   $
1.84
 
Outstanding March 31, 2020
   
3,103,558
    $
2.48
 
Exerciseable March 31, 2020
   
1,495,857
    $
1.98
 
Share-based Payment Arrangement, Option, Exercise Price Range [Table Text Block]
Range of
Exercise Prices
 
 
Number
Outstanding
   
Weighted Average
Remaining
Contractual Life
   
Weighted Average
Exercise
Price
   
 
Number
Exercisable
   
Weighted Average
Exercise
Price
 
$1.31
-
$1.86
   
673,862
     
2.80
    $
1.69
     
628,455
    $
1.68
 
$1.99
-
$1.99
   
1,031,250
     
3.89
    $
1.99
     
562,500
    $
1.99
 
$2.02
-
$3.17
   
264,719
     
1.54
    $
2.46
     
263,187
    $
2.46
 
$3.39
-
$3.40
   
1,133,727
     
6.59
    $
3.39
     
41,715
    $
3.40
 
 
 
 
   
3,103,558
     
4.44
    $
2.48
     
1,495,857
    $
1.98
 
Share-based Payment Arrangement, Expensed and Capitalized, Amount [Table Text Block]
   
Three months ended
   
Six months ended
 
   
March 31
 
 
March 31
 
   
2020
   
2019
   
2020
   
2019
 
Cost of revenues
  $
6,909
    $
4,201
    $
10,551
    $
8,499
 
Selling, general and administrative
   
283,314
     
163,932
     
427,241
     
284,973
 
Research and development
   
5,067
     
3,842
     
15,825
     
12,348
 
    $
295,290
    $
171,975
    $
453,617
    $
305,820